Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kodumudi S. Venkateswaran is active.

Publication


Featured researches published by Kodumudi S. Venkateswaran.


Clinical and Vaccine Immunology | 2006

Simultaneous Detection of Antibodies to Six Nonhuman-Primate Viruses by Multiplex Microbead Immunoassay

Imran H. Khan; Sara Mendoza; JoAnn Yee; Matthew Deane; Kodumudi S. Venkateswaran; Shan S. Zhou; Peter A. Barry; Nicholas W. Lerche; Paul A. Luciw

ABSTRACT To maintain healthy nonhuman primates for use in biomedical research, animals are routinely screened for several infectious agents at most facilities. Commonly, monkey serum samples are tested by conventional immunoassays, such as enzyme-linked immunosorbent assays (ELISAs) or Western blotting, for antibodies to specific infectious agents. For testing for antibodies against multiple agents in each sample, conventional immunoassays are laborious and time-consuming. More efficient immunoassays are needed. Accordingly, we have developed a novel multiplex serodiagnostic system based on individually identifiable, fluorescent microbead sets, where each bead set is coated with antigens from a purified preparation of a specific virus. The coated bead sets are mixed to enable the detection of antibodies to multiple viruses in one serum or plasma sample. These viruses include four agents that are routinely tested for maintenance of specific-pathogen-free monkeys, namely, simian immunodeficiency virus, simian type D retrovirus, simian T-cell lymphotropic virus, and herpes B virus, as well as simian foamy virus and rhesus cytomegalovirus, both of which are commonly found in nonhuman primates. This multiplex microbead immunoassay (MMIA) enabled the simultaneous detection of antibodies to all six viruses in single serum samples as small as 1 microliter. The results obtained by MMIA analysis correlated with results of conventional ELISAs, which detect antibodies to single agents. Thus, this multiplex microbead detection system is an efficient diagnostic modality for serosurveillance of nonhuman primates.


Analytical Chemistry | 2008

Magnetic Bead Based Immunoassay for Autonomous Detection of Toxins

Youngeun Kwon; Christine Hara; Mark G. Knize; Mona H. Hwang; Kodumudi S. Venkateswaran; Elizabeth K. Wheeler; P. M. Bell; Ronald F. Renzi; Julie A. Fruetel; Christopher G. Bailey

We are developing an automated system for the simultaneous, rapid detection of a group of select agents and toxins in the environment. To detect toxins, we modified and automated an antibody-based approach previously developed for manual medical diagnostics that uses fluorescent eTag reporter molecules and is suitable for highly multiplexed assays. Detection is based on two antibodies binding simultaneously to a single antigen, one of which is labeled with biotin while the other is conjugated to a fluorescent eTag through a cleavable linkage. Aqueous samples are incubated with the mixture of antibodies along with streptavidin-coated magnetic beads and a photoactive porphyrin complex. In the presence of antigen, a molecular complex is formed where the cleavable linkage is held in proximity to the photoactive group. Upon excitation at 680 nm, free radicals are generated, which diffuse and cleave the linkage, releasing the eTags. Released eTags are analyzed using capillary gel electrophoresis with laser-induced fluorescence detection. Limits of detection for ovalbumin and botulinum toxoid individually were 4 (or 80 pg) and 16 ng/mL (or 320 pg), respectively, using the manual assay. In addition, we demonstrated the use of pairs of antibodies from different sources in a single assay to decrease the rate of false positives. Automation of the assay was demonstrated in a flow-through format with higher LODs of 32 ng/mL (or 640 ng) each of a mixture of ovalbumin and botulinum toxoid. This versatile assay can be easily modified with the appropriate antibodies to detect a wide range of toxins and other proteins.


Air Monitoring and Detection of Chemical and Biological Agents | 1999

Autonomous system for pathogen detection and identification

Philip Belgrader; William J. Benett; Werner Bergman; Richard G. Langlois; Raymond P. Mariella; Fred P. Milanovich; Robin Miles; Kodumudi S. Venkateswaran; Gary Long; William Nelson

The purpose of this project is to build a prototype instrument that will, running unattended, detect, identify, and quantify BW agents. In order to accomplish this, we have chosen to start with the worlds leading, proven assays for pathogens: surface-molecular recognition assays, such as antibody-based assays, implemented on a high-performance, identification (ID)-capable flow cytometer, and the polymerase chain reaction for nucleic-acid based assays. With these assays, we must integrate the capability to: (1) collect samples form aerosols, water, or surface; (2) perform sample preparation prior to the assays; (3) incubate the prepared samples, if necessary, for a period of time; (4) transport the prepared, incubated samples to the assays; (5) perform the assays; (6) interpret and report the result of the assays. Issues such as reliability, sensitivity and accuracy, quantify of consumables, maintenance schedule, etc. must be addressed satisfactorily to the end user. The highest possible sensitivity and specificity of the assay must be combined with no false alarms. Today, we have assays that can, in under 30 minutes, detect and identify simulants for BW agents at concentrations of a few hundred colony- forming units per ml of solution. If the bio-aerosol sampler of this system collects 1000 1/min and concentrates the respirable particles into 1 ml of solution with 70 percent processing efficiency over a period of 5 minutes, then this translates to a detection/ID capability of under 0.1 agent- containing particle/liter of air.


Health security | 2016

Comprehensive Laboratory Evaluation of a Highly Specific Lateral Flow Assay for the Presumptive Identification of Bacillus anthracis Spores in Suspicious White Powders and Environmental Samples.

Jason Ramage; Kristin W. Prentice; Lindsay DePalma; Kodumudi S. Venkateswaran; Sruti Chivukula; Carol Chapman; Melissa Bell; Shomik Datta; Ajay Singh; Alex R. Hoffmaster; Jawad Sarwar; Nishanth Parameswaran; Mrinmayi Joshi; Nagarajan Thirunavkkarasu; Viswanathan V. Krishnan; Stephen A. Morse; Julie R. Avila; Shashi Sharma; Peter L. Estacio; Larry H. Stanker; David R. Hodge; Segaran Pillai

We conducted a comprehensive, multiphase laboratory evaluation of the Anthrax BioThreat Alert(®) test strip, a lateral flow immunoassay (LFA) for the rapid detection of Bacillus anthracis spores. The study, conducted at 2 sites, evaluated this assay for the detection of spores from the Ames and Sterne strains of B. anthracis, as well as those from an additional 22 strains. Phylogenetic near neighbors, environmental background organisms, white powders, and environmental samples were also tested. The Anthrax LFA demonstrated a limit of detection of about 10(6) spores/mL (ca. 1.5 × 10(5) spores/assay). In this study, overall sensitivity of the LFA was 99.3%, and the specificity was 98.6%. The results indicated that the specificity, sensitivity, limit of detection, dynamic range, and repeatability of the assay support its use in the field for the purpose of qualitatively evaluating suspicious white powders and environmental samples for the presumptive presence of B. anthracis spores.


Journal of Immunological Methods | 2018

Proteomic profiles by multiplex microsphere suspension array

Viswanathan V. Krishnan; Senthamil R. Selvan; Nishanth Parameswaran; Neeraja Venkateswaran; Paul A. Luciw; Kodumudi S. Venkateswaran

Advances in high-throughput proteomic approaches have provided substantial momentum to novel disease-biomarker discovery research and have augmented the quality of clinical studies. Applications based on multiplexed microsphere suspension array technology are making strong in-roads into the clinical diagnostic/prognostic practice. Conventional proteomic approaches are designed to discover a broad set of proteins that are associated with a specific medical condition. In comparison, multiplex microsphere immunoassays use quantitative measurements of selected set(s) of specific/particular molecular markers such as cytokines, chemokines, pathway signaling or disease-specific markers for detection, metabolic disorders, cancer, and infectious agents causing human, plant and animal diseases. This article provides a foundation to the multiplexed microsphere suspension array technology, with an emphasis on the improvements in the technology, data analysis approaches, and applications to translational and clinical research with implications for personalized and precision medicine.


Frontiers in Bioengineering and Biotechnology | 2018

Botulinum neurotoxin detection methods for public health response and surveillance

Nagarajan Thirunavukkarasu; Eric A. Johnson; Segaran Pillai; David B. Hodge; Larry H. Stanker; Travis Wentz; Bal Ram Singh; Kodumudi S. Venkateswaran; Patrick McNutt; Michael Adler; Eric W. Brown; Thomas S. Hammack; Donald H. Burr; Shashi Sharma

Botulism outbreak due to consumption of food contaminated with botulinum neurotoxins (BoNTs) is a public health emergency. The threat of bioterrorism through deliberate distribution in food sources and/or aerosolization of BoNTs raises global public health and security concerns due to the potential for high mortality and morbidity. Rapid and reliable detection methods are necessary to support clinical diagnosis and surveillance for identifying the source of contamination, performing epidemiological analysis of the outbreak, preventing and responding to botulism outbreaks. This review considers the applicability of various BoNT detection methods and examines their fitness-for-purpose in safeguarding the public health and security goals.


Canadian Journal of Infectious Diseases & Medical Microbiology | 2018

Clinical, Serological, and Molecular Observations from a Case Series Study during the Asian Lineage Zika Virus Outbreak in Grenada during 2016

Marco Brenciaglia; Tp Noël; Paul J. Fields; Satesh Bidaisee; Todd E. Myers; William M. Nelson; Neeraja Venkateswaran; Kodumudi S. Venkateswaran; Nishanth Parameswaran; Avi Bahadoor; K Yearwood; Veronica Mapp-Alexander; George Mitchell; A. Desiree LaBeaud; C. N. L. Macpherson

This paper describes the spatial and temporal distribution of cases, demographic characteristics of patients, and clinical manifestations of Zika virus (ZIKV) during the 2016 outbreak in Grenada. The first reported case was recorded in St. Andrew Parish in April, and the last reported case was seen in November, with peak transmission occurring in the last week of June, based on test results. Data were collected from a total of 514 patients, of whom 207 (40%) tested positive for ZIKV. No evidence was found that testing positive for ZIKV infection was related to age, gender, or pregnancy status. Clinical presentation with rash (OR = 2.4, 95% CI = 1.5 to 3.7) or with lymphadenopathy (OR = 1.7, 95% CI = 1.0 to 2.9) were the only reported symptoms consistent with testing positive for ZIKV infection. During the Zika outbreak, the infection rate was 20 clinical cases per 10,000 in the population compared to 41 cases per 10,000 during the chikungunya outbreak in Grenada in 2014 and 17 cases per 10,000 during the dengue outbreak in 2001-2002. Even though the country has employed vector control programs, with no apparent decrease in infection rates, it appears that new abatement approaches are needed to minimize morbidity in future arbovirus outbreaks.


Analytical Chemistry | 1999

A minisonicator to rapidly disrupt bacterial spores for DNA analysis.

Phillip Belgrader; Derek J. Hansford; Gregory T. A. Kovacs; Kodumudi S. Venkateswaran; Raymond P. Mariella; Fred P. Milanovich; Shanavaz Nasarabadi; Margaret Okuzumi; and Farzad Pourahmadi; M. Allen Northrup


Analytical Chemistry | 2003

Multiplexed Liquid Arrays for Simultaneous Detection of Simulants of Biological Warfare Agents

Mary T. McBride; Stuart Gammon; Maurice Pitesky; Tom O'Brien; Thomas W. Smith; Jennifer L. Aldrich; Richard G. Langlois; Bill W. Colston; Kodumudi S. Venkateswaran


Analytical Chemistry | 2003

Autonomous detection of aerosolized bacillus anthracis and Yersinia pestis

Mary T. McBride; Don A. Masquelier; Benjamin J. Hindson; Anthony J. Makarewicz; Steve B. Brown; Keith Burris; Thomas O. Metz; Richard G. Langlois; Kar Wing Tsang; Ruth Bryan; Doug A. Anderson; Kodumudi S. Venkateswaran; Fred P. Milanovich; Bill W. Colston

Collaboration


Dive into the Kodumudi S. Venkateswaran's collaboration.

Top Co-Authors

Avatar

Bill W. Colston

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Fred P. Milanovich

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Mary T. McBride

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Richard G. Langlois

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Shanavaz Nasarabadi

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Anthony J. Makarewicz

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Benjamin J. Hindson

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

John M. Dzenitis

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Raymond P. Mariella

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Bruce D. Henderer

Lawrence Livermore National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge